Non-lymphopenic Pneumocystis Pneumonia in Low-dose Methotrexate Therapy: An Exception to Every Rule

Overview

Journal Respir Med Case Rep

Date 2020 Nov 30

PMID 33251106

Authors

Jorge Lourenco

Patricia Carreira

Affiliations

Soon will be listed here.

Abstract

associated pneumonia (PCP) is one of the most important opportunistic conditions affecting immunocompromised patients, especially those with rheumatic diseases, often associated with lymphopenia and high serum LDH levels. The risk of PCP correlates with immunomodulators' dosage given to control patient's underlying disease. We present a case of a PCP involving a non-lymphopenic patient with psoriatic arthritis treated with low dose of methotrexate.

References

Tokuda H, Sakai F, Yamada H, Johkoh T, Imamura A, Dohi M . Clinical and radiological features of Pneumocystis pneumonia in patients with rheumatoid arthritis, in comparison with methotrexate pneumonitis and Pneumocystis pneumonia in acquired immunodeficiency syndrome: a multicenter study. Intern Med. 2008; 47(10):915-23. DOI: 10.2169/internalmedicine.47.0702. View

Depypere M, Saegeman V, Lagrou K . Typing of Pneumocystis jirovecii by multilocus sequencing: evidence of outbreak?. Eur J Clin Microbiol Infect Dis. 2016; 35(6):911-6. DOI: 10.1007/s10096-016-2615-y. View

Opravil M, Marincek B, FUCHS W, Weber R, Speich R, Battegay M . Shortcomings of chest radiography in detecting Pneumocystis carinii pneumonia. J Acquir Immune Defic Syndr (1988). 1994; 7(1):39-45. View

Akiyama M, Kaneko Y, Takeuchi T . Comparison of the Clinical Characteristics of Pneumocystis Pneumonia between Patients with Rheumatoid Arthritis Being Treated with Biologics and Those Being Treated without Biologics. Biomed Res Int. 2017; 2017:3710652. PMC: 5529629. DOI: 10.1155/2017/3710652. View

Cutolo M, Sulli A, Pizzorni C, Seriolo B, Straub R . Anti-inflammatory mechanisms of methotrexate in rheumatoid arthritis. Ann Rheum Dis. 2001; 60(8):729-35. PMC: 1753808. DOI: 10.1136/ard.60.8.729. View

Alanio A, Bretagne S . detection in asymptomatic patients: what does its natural history tell us?. F1000Res. 2017; 6:739. PMC: 5464226. DOI: 10.12688/f1000research.10619.1. View

Mori S, Cho I, Sugimoto M . A followup study of asymptomatic carriers of Pneumocystis jiroveci during immunosuppressive therapy for rheumatoid arthritis. J Rheumatol. 2009; 36(8):1600-5. DOI: 10.3899/jrheum.081270. View

Kane G, Troshinsky M, Peters S, ISRAEL H . Pneumocystis carinii pneumonia associated with weekly methotrexate: cumulative dose of methotrexate and low CD4 cell count may predict this complication. Respir Med. 1993; 87(2):153-5. DOI: 10.1016/0954-6111(93)90146-q. View

Kovacs J, Masur H . Evolving health effects of Pneumocystis: one hundred years of progress in diagnosis and treatment. JAMA. 2009; 301(24):2578-85. DOI: 10.1001/jama.2009.880. View

10.

Thomas Jr C, Limper A . Pneumocystis pneumonia. N Engl J Med. 2004; 350(24):2487-98. DOI: 10.1056/NEJMra032588. View

11.

Mori S, Cho I, Ichiyasu H, Sugimoto M . Asymptomatic carriage of Pneumocystis jiroveci in elderly patients with rheumatoid arthritis in Japan: a possible association between colonization and development of Pneumocystis jiroveci pneumonia during low-dose MTX therapy. Mod Rheumatol. 2008; 18(3):240-6. DOI: 10.1007/s10165-008-0037-0. View